FDA Approved: LAMIVUDINE AND ZIDOVUDINE — Supplemental Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for Macleods' Lamivudine and Zidovudine fixed-dose combination product (ANDA090679) used to treat HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lamivudine and Zidovudine (Lamivudine and Zidovudine)

Snippet

SUPPL AP for LAMIVUDINE AND ZIDOVUDINE (LAMIVUDINE AND ZIDOVUDINE)